We found that the mechanism between SFN and CDK2 in subnetwork 16 was supported by observations that SFN is a frequently hypermethylated gene41,42 emerging as a new inhibitor of CDK2 in breast cancer cells43. The gene discussed is SFN; the disease is breast cancer.